Literature DB >> 9415095

Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones.

G Pawelec1, D Sansom, A Rehbein, M Adibzadeh, I Beckman.   

Abstract

The growth characteristics in vitro of interleukin 2 (IL 2)-dependent human CD4+ alpha beta-T cell receptor-positive helper T cell clones (TCC) were studied in relation to alterations in surface phenotype, cytokine responsiveness, and susceptibility to activation-induced cell death (AICD). TCC derived from peripheral blood T cells had finite lifespans averaging 33 population doublings (PD) with a recorded maximum lifespan of 80 PD (n = 208). First analyses of the TCC were undertaken at ca. 25 PD, at which time all cells of all TCC expressed high intensity CD45RO and low intensity CD45RA, as well as high intensity CD95 (fas) and MHC class II antigens. The expression of these molecules remained elevated throughout the proliferative lifespan of the clones, but for those TCC which were initially CD28+ (the majority), the density of expression of the latter was diminished in most late-passage clones. Concomitant with this, late-passage cells showed reduced responsiveness to CD28-mediated costimulation by CHO transfectants expressing human CD80 compared to early-passage cells. Additionally, the level of expression of IL 2R gamma c and IL 7R chains was commonly reduced, as was the response to IL 2 and IL 7. Despite unchanged levels of fas expression on TCC with time, late-passage cells were more susceptible to AICD than early, passage cells. These observations further document functional and phenotypic alterations in long-term cultured human T helper cells, which may be considered as biomarkers of immunosenescence. This may contribute to an improved understanding of the mechanisms underlying depressed T cell function in old age.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9415095     DOI: 10.1016/s0531-5565(96)00097-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  12 in total

Review 1.  The immune system in the elderly: activation-induced and damage-induced apoptosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Daniela Monti; Claudio Franceschi
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Immunosenescence: emerging challenges for an ageing population.

Authors:  Danielle Aw; Alberto B Silva; Donald B Palmer
Journal:  Immunology       Date:  2007-02-15       Impact factor: 7.397

4.  Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; N D Hall; D M Sansom
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

Review 5.  Progeroid syndromes: probing the molecular basis of aging?

Authors:  D Kipling; R G Faragher
Journal:  Mol Pathol       Date:  1997-10

Review 6.  Aging and the cornea.

Authors:  R G Faragher; B Mulholland; S J Tuft; S Sandeman; P T Khaw
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

Review 7.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Immunosenescence in vertebrates and invertebrates.

Authors:  Ludmila Müller; Tamas Fülöp; Graham Pawelec
Journal:  Immun Ageing       Date:  2013-04-02       Impact factor: 6.400

Review 9.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  Immunity, ageing and cancer.

Authors:  Evelyna Derhovanessian; Rafael Solana; Anis Larbi; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-09-24       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.